iAnthus Capital (CSE:IAN)

  • Symbol:CSE:IAN
  • Ticker 2:OTC:ITHUF
  • Sector:Healthcare
  • Industry:Pharmaceutical
  • CEO:Hadley Ford
  • Founded:2013

iAnthus Capital (CSE:IAN) Stock Price

iAnthus Capital (CSE:IAN) Company Overview

iAnthus (CNSX: IAN) was founded by experienced entrepreneurs, with backgrounds in operations, investment banking, corporate finance, law and health care, who each brought a unique set of skills and expertise to the table. A change in strategy in early 2018, led the company to move from passive investors, to executive owners of their investments. All hands on deck from there.

The company now operates across 11 U.S. States and owns 23 dispensaries, boasting the full gamut of vertically-integrated cannabis operations; from cultivation to processing and retailing. The company's investments are most notable in Massachusetts, New York and Florida, Nevada, Arizona and California which all exist in markets with large populations, strong growth characteristics and limited licenses.

iAnthus was the first multi-state operator in the U.S. to go public and raise money in Canada, and in February the company entered into a merger with MPX Bioceuticals Corp. The combination, valued at C$835 million, was at the time the largest public cannabis transaction in the U.S. The company also received a $50 million investment from Gotham Green Partners, considered one of the shrewdest in the industry.

The company also recently acquired 'CBD For Life' for $10.4 Million to gain access to CBD For Life's suite of CBD products, which are currently distributed to over 1,000 retail locations throughout 46 U.S. states.

iAnthus Capital (CSE:IAN) Financials

More From iAnthus Capital...

Milestones in Massachusetts – An iAnthus Update
CBD For Life Partners With Dillards Inc
Cannabis Coup – CEO Bruce Linton Axed from Canopy Growth
GrowHealthy Announces Grand Opening of Daytona and Orlando Dispensaries
iAnthus Closes Deal to Acquire CBD For Life for $10.4 Million
Women & Weed: The Female Side of the Cannabis Industry
iAnthus – the Dark Horse of the US Cannabis Market
The American Cannabis Industry
iAnthus Q1 Revenue up 22% From Previous Quarter
Dynamic Duo – MediPharm Joins Forces with Cronos and Announces Strong Q1 Results
Load More Results

Investor Presentation

The latest update from the company

Click Here
Stay updated about
this company

Signup to get updates.


Hadley Ford
Co-Founder & CEO
Hadley Ford is a former Goldman Sachs Investment Banker and CEO of ProCure with with more than 30 years of experience. He also spent sixteen years on Wall Street, working with Fidelity, First Boston, Bank of America and Goldman Sachs,

Ford has an M.B.A. from Stanford University's Graduate School of Business and a B.S. in Business Admin from Boston University.

Randy Maslow
Co-Founder & President
Randy Maslow is a Former Executive at XO Communications, which was eventually sold to Verizon for $1.8 billion in February 2016.

He is also a Co-Founder of Internet Gaming Entertainment U.S., where he served as Senior Vice President, as well as being General Counsel and a member of the Board of Directors.
John Henderson
Chief Operating Officer
John Henderson previously served as the COO and Chief Development Officer of ProCure Treatment Centres, where he managed the development of four $150 million plus proton therapy centres.

He has also advised major academic research centres in Europe and the Middle East on the development of proton therapy projects, and has 15 years experience at the construction services firm, George B.H. Macomber Company, which includied 5 years serving as President.
Julius Kalcevich
Chief Financial Officer
Julius Kalcevich is a former partner at BG Partners Corp, and has more than 15 Years of experience in U.S. and Canadian banking industries.

He previously served as a partner and leader of cannabis investments at BG Partners Corp, and was also a formerly a investment banking director at CIBC and Dundee Capital Markets, where he worked on over 40 transactions worth over $5 billion.